{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:54:18Z","timestamp":1787756058352,"version":"build-2784847793"},"reference-count":68,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"LEO Pharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Actinic keratoses (<jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>) are common photo\u2010induced cutaneous lesions that may progress to invasive squamous\u2010cell carcinoma and serve as a risk marker for skin cancer. Although numerous studies present the various therapeutic options for <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>, publications that can be used to pragmatically guide dermatologists in their daily practice are limited. National and international guidelines have been published, however, they are based on clinical trials with highly selected patient populations and do not always capture the range of patients seen in everyday practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this expert panel of <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>rench dermatologists was to present an analysis of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> geared towards everyday practice, to express an informed opinion about most recent treatments, and to propose a treatment algorithm for <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> for daily practice in <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>rance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Over a 12\u00a0month period, six expert dermatologists in the field of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">AKT<\/jats:styled-content>eam<jats:sup>TM<\/jats:sup> expert panel) met regularly to formulate an opinion about treatment in everyday practice compared with the analysis of the literature and guidelines published since 1990.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Definitions, terminology, diagnosis and risk factors were summarized. Data from the literature and current practices related to the initial evaluation, indications for biopsy, therapeutic indications, therapeutic options and effectiveness, monitoring and prevention were discussed. A pragmatic treatment algorithm was formalized according to current data available. This practical algorithm distinguishes between different clinical situations depending on the number of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>, their hyperkeratotic or suspicious nature, and includes cryotherapy, curettage\u2010electrocoagulation, 5% 5\u2010fluorouracil, 3% diclofenac sodium, 5% imiquimod, 150 and 500\u00a0\u03bcg\/g ingenol mebutate, lasers, photodynamic therapy and surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This up\u2010to\u2010date expert opinions about <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> and its treatment provide a management strategy and practical treatment algorithm for <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>rench dermatologists to use.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.12434","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T07:15:38Z","timestamp":1394522138000},"page":"1141-1149","source":"Crossref","is-referenced-by-count":95,"title":["Management of actinic keratosis: a practical report and treatment algorithm from <scp>AKT<\/scp>eam<scp><sup>TM<\/sup><\/scp> expert clinicians"],"prefix":"10.1111","volume":"28","author":[{"given":"B.","family":"Dr\u00e9no","sequence":"first","affiliation":[{"name":"Department of Dermato cancerology University Hospital Hotel Dieu Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Amici","sequence":"additional","affiliation":[{"name":"Cabinet de dermatologie Rive Droite Cenon France"},{"name":"Dermatologie H\u00f4pital Saint\u2010Andr\u00e9 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Basset\u2010Seguin","sequence":"additional","affiliation":[{"name":"Dermatologie H\u00f4pital Saint\u2010Louis AP\u2010HP Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[{"name":"Dermatologie H\u00f4pitaux Universitaires de Strasbourg Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Claudel","sequence":"additional","affiliation":[{"name":"Cabinet de dermatologie Tours France"},{"name":"Dermatologie CHU Clocheville Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Richard","sequence":"additional","affiliation":[{"name":"Dermatology Department Aix\u2010Marseille Univ UMR 911 INSERM CRO2 \u201cCentre de recherche en oncologie biologique et oncophamacologie\u201d Timone Hospital Assistance Publique H\u00f4pitaux de Marseille Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03541.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08544.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.535"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.048"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910460303"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103342"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000112925"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0151-9638(09)75172-5"},{"key":"e_1_2_6_10_1","first-page":"228","article-title":"Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinome and precursor lesions. Guidelines","volume":"111","author":"Haute AS","year":"2010","journal-title":"Rev Stomatol Chir Maxillofac"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04296.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90191-4"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07692.x"},{"key":"e_1_2_6_14_1","first-page":"713","article-title":"Italian guidelines and therapeutic algorithm for actinic keratoses","volume":"144","author":"Rossi R","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_6_15_1","first-page":"599","article-title":"Guidelines for the management of actinic keratoses","volume":"16","author":"Stockfleth E","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_16_1","first-page":"651","article-title":"Development of a treatment algorithm for actinic keratoses: a European Consensus","volume":"18","author":"Stockfleth E","year":"2008","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1684\/ejd.2013.1923","article-title":"Therapeutic strategies for actinic keratoses \u2013 a systematic review","volume":"23","author":"Nashan D","year":"2013","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_18_1","first-page":"CD007869","article-title":"Interventions for non\u2010metastatic squamous cell carcinoma of the skin","author":"Lansbury L","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_19_1","first-page":"CD004415","article-title":"Interventions for actinic keratoses (Protocol)","author":"Gupta AK","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07121.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb06644.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00048.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680060103013"},{"key":"e_1_2_6_24_1","first-page":"201","article-title":"Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications","volume":"87","author":"Feldman SR","year":"2011","journal-title":"Cutis"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91658-3"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00467.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1988.01670070027013"},{"key":"e_1_2_6_28_1","first-page":"3604","article-title":"p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization","volume":"55","author":"Kanjilal S","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10887.x"},{"key":"e_1_2_6_30_1","first-page":"335","article-title":"Actinic keratosis. How to differentiate the good and the bad ones?","volume":"16","author":"Quaedvlieg PJ","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08271.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310012118"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119649"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07470.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08488.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.687088"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10893.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.02.014"},{"key":"e_1_2_6_39_1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit Metvixia\u00ae VIDAL2012."},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04432.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12031"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.031"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.49"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.03029.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04386.x"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70113-G"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04561.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(01)00246-9"},{"key":"e_1_2_6_49_1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit Efudix\u00ae VIDAL2012."},{"key":"e_1_2_6_50_1","first-page":"144","article-title":"Comparison of 5% 5\u2010fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp","volume":"6","author":"Tanghetti E","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80012-1"},{"key":"e_1_2_6_52_1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit Aldara\u00ae VIDAL2012."},{"key":"e_1_2_6_53_1","first-page":"1101","article-title":"A randomized, double\u2010blinded, placebo\u2010controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses","volume":"9","author":"Jorizzo JL","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.010"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.022"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.4.467"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.01.047"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07942.x"},{"key":"e_1_2_6_59_1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit Solaraze\u00ae VIDAL2012."},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01324.x"},{"key":"e_1_2_6_61_1","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit Picato\u00ae extract from EPAR 29 November 2012 (EMA Website)."},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111170"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.062"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.063"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.10"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S31930"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.09.051"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09453.x"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.005"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12434","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.12434","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.12434","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.12434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:50:23Z","timestamp":1695545423000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.12434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/jdv.12434"],"URL":"https:\/\/doi.org\/10.1111\/jdv.12434","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]}}}